Picture of Nyxoah SA logo

NYXH — Nyxoah SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Nyxoah Says FDA Regulatory Submission For Company's Genio® Device Is Complete, U.S. Approval On Track For End Of 2024

Sept 2 (Reuters) - Nyxoah SA  NYXH.BR :
    * NYXOAH SA - FDA REGULATORY SUBMISSION FOR COMPANY'S GENIO®
DEVICE IS COMPLETE, U.S. APPROVAL ON TRACK FOR END OF 2024
    * NYXOAH SA - U.S. COMMERCIAL LAUNCH EXPECTED AT BEGINNING
OF
2025, FULLY FUNDED WITH OVER EUR 85 MILLION IN NEW CAPITAL
RAISED

Source text for Eikon:  ID:nGNEQZMlL 
Further company coverage:  NYXH.BR 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Nyxoah SA

See all news